Article de revue
Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study
The 13-valent pneumococcal conjugate vaccine (PCV13) protects against key serotypes that increased after routine immunisation with the seven-valent vaccine (PCV7), but its potential for herd protection and serotype replacement is uncertain. The aim of this study was to analyse the effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction.
Auteurs
Langues
- Anglais
Année de publication
2015
Journal
The Lancet Infectious Diseases
Volume
5
Type
Article de revue
Catégories
- Prestation de services
Maladies
- Infection à pneumocoque
Pays
- Royaume-Uni
Mots-clés
- Introduction de nouveaux vaccins
- Suivi de performance
Régions de l'OMS
- Région européenne
